# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Multiple sclerosis

MS
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 131-140 of 487 results.
Evaluation of a Spasticity Management Program for People With Multiple Sclerosis
Status: Recruiting
Last Changed: Oct 26, 2020
First Received: May 25, 2017
Disease(s): Multiple Sclerosis
Intervention(s): Spasticity Take Control, Stretching for People with MS: An Illustrated Manual
Locations: VA Portland Health Care System, Portland, OR, Portland, Oregon, United States
Patient Acceptable Symptomatic State and Minimal Clinically Important Difference of the Fatigue in Multiple Sclerosis (SeDiF_SEP)
Status: Recruiting
Last Changed: Jul 08, 2020
First Received: Sep 07, 2018
Disease(s): Multiple Sclerosis
Locations: CIC 1433 Épidémiologie clinique, Inserm, CHRU de Nancy, Université de Lorraine, Vandoeuvre Les Nancy, France
Copaxone Subcutaneous Injection Syringe Special Drug Use-Result Investigation (All-Case Investigation) "Prevention of Relapse of Multiple Sclerosis"
Status: Recruiting
Last Changed: Jul 24, 2018
First Received: Jul 06, 2017
Disease(s): Multiple Sclerosis
Intervention(s): Glatiramer acetate
Locations: Takeda selected site, Tokyo, Japan
Neuropsychological Management of Multiple Sclerosis: Benefits of a Computerised Semi-autonomous At-home Cognitive Rehabilitation Programme
Status: Recruiting
Last Changed: Jan 27, 2020
First Received: Mar 20, 2018
Disease(s): Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis
Intervention(s): Cognitive rehabilitation, Standard Psychological care
Locations: University Hospital of Caen, Caen, Calvados, France
Prebiotic vs Probiotic in Multiple Sclerosis
Status: Recruiting
Last Changed: Mar 18, 2020
First Received: Jul 31, 2019
Disease(s): Multiple Sclerosis, Clinically Isolated Syndrome (CIS)
Intervention(s): Prebiotics (Prebiotin Prebiotic Fiber Stick Pac), Probiotics (Visbiome®)
Locations: Columbia University Medical Center, New York, New York, United States
University of Pittsburg, Pittsburgh, Pennsylvania, United States
Dendritic Cells Therapy Combined With Immunomodulatory Treatment in Multiple Sclerosis
Status: Not yet recruiting
Last Changed: Aug 28, 2020
First Received: Aug 28, 2020
Disease(s): Relapsing-Remitting Multiple Sclerosis
Intervention(s): Autologous peripheral blood differentiated adult tolerogenic dendritic cells expanded, Placebo
Locations: Hospital Moisés Broggi, Hospitalet de Llobregat, Barcelona, Spain
Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain
Hospital Clínic de Barcelona, Barcelona, Spain
Hospital de Sant Pau, Barcelona, Spain
Hospital del Mar, Barcelona, Spain
... and 1 other locations.
Effects of Ocrelizumab on B-cell Tolerance Defect in Relapsing Multiple Sclerosis
Status: Recruiting
Last Changed: Sep 25, 2020
First Received: Feb 10, 2020
Disease(s): Multiple Sclerosis, Relapsing-Remitting
Intervention(s): Ocrelizumab
Locations: Johns Hopkins University, Baltimore, Maryland, United States
Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques
Status: Recruiting
Last Changed: Nov 12, 2020
First Received: May 27, 2016
Disease(s): Multiple Sclerosis
Intervention(s): Methylprednisolone, Methylprednisolone
Locations: National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Personalized Extended Interval Dosing of Natalizumab in Relapsing Remitting Multiple Sclerosis
Status: Recruiting
Last Changed: May 19, 2020
First Received: Jan 13, 2020
Disease(s): Relapsing Remitting Multiple Sclerosis
Intervention(s): Personalized extended interval dosing of natalizumab, Standard interval dosing
Locations: OLVG, Amsterdam, Netherlands
VU medical center, Amsterdam, Netherlands
Rijnstate Hospital, Arnhem, Netherlands
Amphia Hospital, Breda, Netherlands
Jeroen Bosch Hospital, Den Bosch, Netherlands
... and 11 other locations.
Discontinuing Disease-modifying Therapies in Stable Relapsing - Onset Multiple Sclerosis (DOT-MS).
Status: Recruiting
Last Changed: Oct 19, 2020
First Received: Feb 07, 2020
Disease(s): Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive
Intervention(s): DMT
Locations: Amsterdam UMC, Amsterdam, Netherlands